Wes Kaupinen insider trades
Open-market stock purchases and sales by Wes Kaupinen, President and CEO at Palvella Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 5, 2026 | PVLA Palvella Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- PVLA Palvella Therapeutics, Inc: other filings, last Feb 5, 2026